Company Overview and News

 
Lanka Graphite gets ready to commence graphite production in Sri Lanka

2017-09-25 proactiveinvestors.com.au
Lanka Graphite Ltd (ASX:LGR) has been granted its first artisanal mining license (AML) in Sri Lanka to commence small scale graphite production.
Upvote Downvote

 
Lanka Graphite Ltd raises $1.4M for potential graphite mining operations

2016-10-07 proactiveinvestors.com.au
Lanka Graphite Ltd (ASX:LGR) has entered into agreements to raise $1.42 million through the issue of unsecured convertible notes. Funds raised will be used for working capital purposes and to further advance the current memorandum of understanding that refers to the potential commercialisation of the Sri Lanka government graphite mining operations. Subject to shareholder approval, the notes will be convertible into shares priced at $0.
Upvote Downvote

 
Lanka Graphite Ltd raises $1.4M for potential graphite mining operations

2016-10-03 proactiveinvestors.com.au
Lanka Graphite Ltd (ASX:LGR) has entered into agreements to raise $1.42 million through the issue of unsecured convertible notes. Funds raised will be used for working capital purposes and to further advance the current memorandum of understanding that refers to the potential commercialisation of the Sri Lanka government graphite mining operations. Subject to shareholder approval, the notes will be convertible into shares priced at $0.
Upvote Downvote

 
TBG Diagnostics Ltd to generate higher sales on Taiwanese acquisition

2016-06-29 proactiveinvestors.com.au
TBG Diagnostics Ltd (ASX:TDL) formerly Progen Pharmaceuticals is focused on the discovery, development and commercialisation of small molecule therapeutics primarily for the treatment of cancer.
Upvote Downvote

 
Lanka Graphite Ltd looks to take leading role in graphite industry in Sri Lanka

2016-06-07 proactiveinvestors.com.au
Lanka Graphite Ltd (ASX:LGR) has completed a feasibility study on development options for the vein graphite and graphene industry in Sri Lanka. This could involve graphite assets owned by the government. The feasibility study is a progression from the memorandum of understanding signed with the Sri Lankan government in December, 2015. Next step would be a formal agreement with the Sri Lankan government.
Upvote Downvote

 
 
 
Appendix 3B

2016-02-05 asx.com.au
Upvote Downvote

 
Cleansing Prospectus

2016-02-02 asx.com.au
Upvote Downvote

 

Related Articles

GNCA: Genocea Biosciences Analysis and Research Report

2018-04-25 - Asif

Overview Genocea Biosciences is a biopharmaceutical company that discovers and develops novel cancer vaccines. The company use its proprietary discovery platform, ATLAS, to recall a patient’s pre-existing CD4+ and CD8+ T cell immune responses to their tumor to identify antigens for inclusion in vaccines that are designed to act through T cell (or cellular) immune responses. The company believe that using ATLAS to identify antigens for inclusion in cancer vaccines could lead to more immunogenic and efficacious cancer vaccines. In September 2017, the company announced a strategic shift to immuno-oncology and a focus on the development of neoantigen cancer vaccines. Currently, all of its research programs and product candidates in active development are at the preclinical stage. The company's most advanced program is its preclinical immuno-oncology program, GEN-009, a neoantigen cancer vaccine. The GEN-009 program uses ATLAS to identify patient neoantigens, or newly formed anti...

AMZN: Amazon.com, Inc Analysis and Research Report

2018-04-25 - Asif

Overview Amazon.com opened its virtual doors on the World Wide Web in July 1995. The company seek to be Earth’s most customer-centric company. Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. In each of its segments, the company serve its primary customer sets, consisting of consumers, sellers, developers, enterprises, and content creators. In addition, the company provide services, such as advertising services and co-branded credit card agreements. Amazon has organized its operations into three segments: North America, International, and Amazon Web Services (“AWS”). These segments reflect the way the Company evaluates its business performance and manages its operations. Additional information on its operating segments and its net sales is contained in Item 8 of Part II, “Financial Statements and Supplementary Data—Note 11—Segment Information.” The compan...

LPCN: Lipocine Inc Analysis and Research Report

2018-04-23 - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...